Brief: Krystal Biotech Announces Third Quarter 2023 Financial Results And Provides Business Update
06/11/2023 12:04
Nov 6 (Reuters) - Krystal Biotech Inc KRYS.O :
* KRYSTAL BIOTECH ANNOUNCES THIRD QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* KRYSTAL BIOTECH INC - REMAINS ON TRACK TO COMMENCE PHASE 2
COHORT OF ITS KB105-02 (JADE-1) TRIAL FOR TREATMENT OF TGM1-ARCI
IN 2024
* KRYSTAL BIOTECH INC - CASH, CASH EQUIVALENTS, AND
INVESTMENTS
TOTALED $598.6 MILLION ON SEPTEMBER 30, 2023
Source text for Eikon: ID:nGNX4qv6dY
Further company coverage: KRYS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion